# Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood

> **NCT04496154** · NA · COMPLETED · sponsor: **May Faraj, PDt, PhD** · enrollment: 41 (actual)

## Conditions studied

- Type 2 Diabetes
- Insulin Sensitivity/Resistance
- Inflammatory Response
- Fatty Acids, Omega-3

## Interventions

- **DIETARY_SUPPLEMENT:** Omega-3 fatty acids (2.7 g/d, EPA:DHA, 2:1)

## Key facts

- **NCT ID:** NCT04496154
- **Lead sponsor:** May Faraj, PDt, PhD
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09-05
- **Primary completion:** 2020-01-22
- **Final completion:** 2020-02-24
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2025-02-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04496154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04496154, "Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04496154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*